Guangdong VTR Bio-Tech Balance Sheet Health
Financial Health criteria checks 5/6
Guangdong VTR Bio-Tech has a total shareholder equity of CN¥2.7B and total debt of CN¥83.6M, which brings its debt-to-equity ratio to 3.1%. Its total assets and total liabilities are CN¥3.0B and CN¥280.8M respectively.
Key information
3.1%
Debt to equity ratio
CN¥83.55m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.07b |
| Equity | CN¥2.67b |
| Total liabilities | CN¥280.75m |
| Total assets | CN¥2.95b |
Recent financial health updates
No updates
Recent updates
Guangdong VTR Bio-Tech's (SZSE:300381) Soft Earnings Are Actually Better Than They Appear
May 02
There's No Escaping Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Muted Revenues Despite A 35% Share Price Rise
Apr 30Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Mar 08Financial Position Analysis
Short Term Liabilities: 300381's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥228.7M).
Long Term Liabilities: 300381's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥52.0M).
Debt to Equity History and Analysis
Debt Level: 300381 has more cash than its total debt.
Reducing Debt: 300381's debt to equity ratio has reduced from 64.9% to 3.1% over the past 5 years.
Debt Coverage: 300381's debt is well covered by operating cash flow (252.6%).
Interest Coverage: Insufficient data to determine if 300381's interest payments on its debt are well covered by EBIT.